Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002013568 | SCV002292799 | likely pathogenic | Multiple acyl-CoA dehydrogenase deficiency | 2023-02-01 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ETFDH protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Studies have shown that this missense change alters ETFDH gene expression (PMID: 24522293). ClinVar contains an entry for this variant (Variation ID: 1507657). This missense change has been observed in individual(s) with multiple acyl-CoA dehydrogenase deficiency (PMID: 24522293). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 529 of the ETFDH protein (p.His529Arg). |
Ce |
RCV003886547 | SCV004704305 | likely pathogenic | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | ETFDH: PM2, PM3, PP3, PS3:Supporting |